Abstract
This chapter discusses ovarian diseases such as the failure of ovarian follicular function that results in infertility. Failure of follicle formation or early follicle loss can result in failure of pubertal progression and severe early osteoporosis. Less severe disruption or later follicle loss can result in premature ovarian failure or early menopause. Disruption of the normal balance of hormone production can alter the ovarian cycle and adversely affect other organ systems such as the central nervous or cardiovascular systems.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Selected References
Aittomaki K, Lucena JL, Pakarinen P, et al. Mutation in the follicle stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 1995;82:959–968.
Barbieri RL, Smith S, Ryan KJ. The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism. Fertil Steril 1988;50:197–212.
Bolivar J, Guelman S, Iglesias C, Ortiz M, Valdivia MM. The fragile-X-related gene FXR1 is a human autoantigen processed during apoptosis. J Biol Chem 1998;273(27):17,122–17,127.
Cataldo NA, Dumesic DA, Goldsmith PC, Jaffe RB. Immunolocalization of Fas and Fas ligand in the ovaries of women with polycystic ovary syndrome: relationship to apoptosis. Hum Reprod 2000;15:1889–1897.
Chandrasekher YA, Hutchison JS, Zelinski-Wooten MB, Hess DL, Wolf DP, Stouffer RL. Initiation of periovulatory events in primate follicles using recombinant and native human luteinizing hormone to mimic the midcycle gonadotropin surge. J Clin Endocrinol Metab 1994;79:298–306.
Daniels TL, Berga SL. Resistance of gonadotropin releasing hormone to drive sexsteroid-induced suppression in hyperandrogenic anovulation. J Clin Endocrinol Metab 1997;82:4179–4183.
Donovan PJ. Growth factor regulation of mouse primordial germ cell development. Curr Top Dev Biol 1994;29:189–225.
Dunaif A, Thomas A. Current concepts in the polycystic ovary syndrome. Annu Rev Med 2001;52:401–419.
Ehrmann DA, Barnew RB, Rosenfield RL, Cavaghan MK, Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 1999;22:141–146.
Faddy MJ, Gosden RG. A mathematical model of follicle dynamics in the human ovary. Hum Reprod 1995;10:770–775.
Franks S, Gharani N, McCarthy M. Genetics and infertility II: candidate genes in polycystic ovary syndrome. Hum Reprod Update 2001;7: 405–410.
Gharani N, Waterworth DM, Batty S, et al. Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism. Hum Mol Genet 1997;6:397–402.
Gilling-Smith C, Story H, Rogers V, Franks S. Evidence for a primary abnormality of the cal cell steroidogenesis in the polycystic ovary syndrome. Clin Endocrinol (Oxf) 1997;47:9309.
Gulyas BJ, Hodgen GD, Tullner WW, Ross GT. Effects of fetal or maternal hypophysectomy on endocrine organs and body weight in infant rhesus monkeys (Macaca mulatta): with particular emphasis on oogenesis. Biol Reprod 1977;16:216–227.
Hirshfield AN. Development of follicles in the mammalian ovary. Int Rev Cytol 1991;124:43–101.
Hoek A, van Kasteren Y, de Haan-Meulman M, Hooijkaas H, Schoemaker J, Drexhage HA. Analysis of peripheral blood lymphocyte subsets, NK cells, and delayed type hypersensitivity skin test in patients with premature ovarian failure. Am J Reprod Immunol 1995;33:495–502.
Homburg R, Amsterdam A. Polycystic ovary syndrome-loss of the apoptotic mechanism in the ovarian follicles? J Endocrinol Invest 1998;9: 552–557.
Horie K, Fujita J, Takakura K, et al. The expression of c-kit protein in human adult and fetal tissues. Hum Reprod 1993;8:1955–1962.
Hsu SY, Hsueh AJW. Tissue-specific Bcl-2 protein partners in apoptosis: an ovarian paradigm. Physiol Rev 2000;80(2):593–614.
Kaiser UB. The pathogenesis of the ovarian hyperstimulation syndrome. N Engl J Med 2003;349:729–732.
Kaufman FR, Donnell GN, Roe TF, Kogut MD. Gonadal function in patients with galactosaemia. J Inherit Metab Dis 1986;9:140–146.
Knochenhauer ES, Key TJ, Kahsar-Miller M, et al. Prevalence of polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998;83:3078–3082.
Kol S, Adashi EY. Intraovarian factors regulating ovarian function. Curr Opin Obstet Gynecol 1995;7:209–213.
Latronico AC, Anasti J, Arnhold IJ, et al. Brief report: testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone-receptor gene. N Engl J Med 1996;334:507–512.
Legro RS. The genetics of polycystic ovary syndrome. Am J Med 1995; 98:9S–16S.
Legro RS, Kunselman AR, Dodson WC, Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus an impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 1999;84:165–169.
Lemieux S, Lewis GF, Ben-Chetrit A, Steiner G, Greenblatt EM. Correction of hyperandrogenemia by laparoscopic ovarian cautery in women with polycystic ovary syndrome is not accompanied by improved insulin sensitivity or lipid-lipoprotein levels. J Clin Endocrinol Metab 1999;11:4278–4282.
Leonardsson G, Peng XR, Liu K, et al. Ovulation efficiency is reduced in mice that lack plasminogen activator gene function: functional redundancy among physiological plasminogen activators. Proc Natl Acad Sci USA 1995;92:12,446–12,450.
Leondires MP, Berga SL. Role of GnRH drive in the pathophysiology of polycystic ovary syndrome. J Endocrinol Invest 1998;21:476–485.
Leung PC, Steele GL. Intracellular signaling in the gonads. Endocr Rev 1992;13:476–498.
Loucks TL, Talbott EO, McHugh K, Keelan M, et al. Do polycystic appearing ovaries affect the risk of cardiovascular disease among women with polycystic ovary syndrome? Fertil Steril 2000;74:547–552.
Luoh SW, Bain PA, Plakiewicz RD, et al. Zfx mutation results in small animal size and reduced germ cell number in male and female mice. Development 1997;124:2275–2284.
Lyons J, Landis CA, Harsh G, et al. Two G protein oncogenes in human endocrine tumors. Science 1990;249:655–659.
Matthews CH, Borgato S, Beck-Peccoz P, et al. Primary amenorrhoea and infertility due to a mutation in the beta-subunit of follicle-stimulating hormone. Nat Genet 1993;5:83–86.
McGee EA, Hsueh AJ. Initial and cyclic recruitment of ovarian follicles. Endocr Rev 2000;21(2):200–214.
McGee EA, Hsu SY, Kaipia A, Hsueh AJ. Cell death and survival during ovarian follicle development. Mol Cell Endocrinol 1998;140(1,2):15–18.
cGrath SA, Esquela AF, Lee SJ. Oocyte-specific expression of growth/differentiation factor-9. Mol Endocrinol 1995;9:131–136.
McNatty KP, Smith P, Hudson NL, et al. Development of the sheep ovary during fetal and early neonatal life and the effect of fecundity genes. Reprod Fertil Suppl 1995;49:123–135.
Morales A, Laughlin G, Butzow T, Maheshwari H, Baumann G, Yen SSC. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features. J Clin Endocrinol Metab 1996;81:2854–2864.
Nelson VL, Qin KN, Rosenfield RL, et al. The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome. J Clin Endocrinol Metab 2001;86:5925–5933.
Polson DW, Wadsworth J, Adams J, Franks S. Polycystic ovaries: a common finding in normal women. Lancet 1988;I:870–872.
Rabinovici J, Blankstein J, Goldman B, et al. In vitro fertilization and primary embryonic cleavage are possible in 17 alpha-hydroxylase deficiency despite extremely low intrafollicular 17 beta-estradiol. J Clin Endocrinol Metab 1989;68:693–697.
Richards JS. Hormonal control of gene expression in the ovary. Endocr Rev 1994;15:725–751.
Santoro N. Mechanisms of premature ovarian failure. Ann Endocrinol (Paris) 2003;64(2):87–92.
Smits G, Olatunbosun O, Delbaere A, et al. Brief Report Ovarian hyper-stimulation syndrome due to a mutation in the follicle stimulating hormone receptor. N Engl J Med 2003;349:760–766.
Somers JP, Benyo DF, Little-Ihrig L, Zeleznik AJ. Luteinization in pri-mates is accompanied by loss of a 43-kilodalton adenosine 3′,5′ mono-phosphate response element-binding protein isoform. Endocrinology 1995;136:4762–4768.
Stein IF, Leventhal ML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1935;29:181–191.
Talbot JA, Bicknell EJ, Rajkhowa M, Krook O’Rahilly S, ClaytonZ RN. Molecular scanning of the insulin receptor gene in women with polycystic ovarian syndrome. J Clin Endocrinol Metab 1996;81:1979–1983.
Tsafriri A. Ovulation as a tissue remodelling process. Proteolysis and cumulus expansion. Adv Exp Med Biol 1995;377:121–140.
Urbanek M, Legro RS, Driscoll DA, et al. Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage with follistattin. Proc Natl Acad Sci USA 1999;96:8573–8578.
van der Meer M, Hompes P GA, de Boer J AM, et al. Cohort size rather than follicle stimulating hormone threshold concentration determines ovarian sensitivity in polycystic ovary syndrome. J Clin Endocrinol Metab 1998;83:423–426.
Vasseur C, Rodien P, Beau I, et al. A chorionic gonadotropin sensitive mutation in the follicle stimulating hormone receptor as a cause of familial gestational spontaneous ovarian hyperstimulation syndrome. N Engl J Med 2003;349:753–759.
Waterworth DM, Bennett ST, Gharani N, et al. Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome. Lancet 1997;349:986–990.
Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 1991;325:1688–1695.
Wild RA. Metabolic aspects of polycystic ovary syndrome. Semin Reprod Endocrinol 1997;15:105–110.
Young RH, Scully RE. Endocrine tumors of the ovary. Curr Top Pathol 1992;85:113–164.
Zhang LH, Rodriguez H, Ohno S, Miller WL. Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome. Proc Natl Acad Sci USA 1995;92:10,619–10,623.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc.
About this chapter
Cite this chapter
McGee, E.A., Loucks, T.L. (2006). Ovarian Diseases. In: Runge, M.S., Patterson, C. (eds) Principles of Molecular Medicine. Humana Press. https://doi.org/10.1007/978-1-59259-963-9_46
Download citation
DOI: https://doi.org/10.1007/978-1-59259-963-9_46
Publisher Name: Humana Press
Print ISBN: 978-1-58829-202-5
Online ISBN: 978-1-59259-963-9
eBook Packages: MedicineMedicine (R0)